CANbridge Pharmaceuticals Inc.

Rachunek Zysków i Strat


index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Rok finansowy 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024
Kwartał Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Data 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31
Przychód (mln) 1 1 5 5 7 6 9 9 17 17 22 22 22 22 30 30 22 22 20 20
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 783.4% 369.0% 88.0% 88.0% 164.9% 208.0% 133.2% 133.2% 24.0% 24.0% 35.2% 35.2% 4.0% 4.0% -32.62% -32.62%
Marża brutto 61.3% 36.3% 59.3% 59.3% 55.9% 56.3% 62.9% 62.9% 63.8% 63.8% 60.4% 60.4% 62.0% 62.0% 62.7% 62.7% 65.7% 65.7% 61.7% 61.7%
Koszty i Wydatki (mln) 130 27 349 349 119 236 376 376 141 141 139 139 128 128 113 113 132 132 81 81
EBIT (mln) -29 -52 -75 -75 -104 -262 -145 -145 -117 -117 -112 -112 -101 -101 -82 -82 -110 -110 -61 -61
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 261.2% 404.0% 92.0% 92.0% 12.5% -55.21% -22.74% -22.74% -13.45% -13.45% -26.78% -26.78% 8.1% 8.1% -25.94% -25.94%
EBIT (%) -3884.64% -4318.39% -1494.42% -1494.42% -1588.21% -4640.54% -1525.93% -1525.93% -674.80% -674.80% -505.44% -505.44% -471.11% -471.11% -273.70% -273.70% -489.49% -489.49% -300.81% -300.81%
Przychody fiansowe (mln) 1 1 1 1 0 2 1 1 1 1 0 0 2 2 0 3 0 0 0 0
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Amortyzacja (mln) 0 3 6 6 3 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3
EBITDA (mln) -28 -49 -70 -70 -101 -260 -143 -143 -115 -115 -109 -109 -99 -99 -79 -79 -106 -106 -57 -58
EBITDA(%) -3838.95% -4093.51% -1382.23% -1382.23% -1541.91% -4610.50% -1503.19% -1503.19% -662.07% -662.07% -494.80% -494.80% -458.96% -458.96% -262.68% -262.68% -475.42% -475.42% -285.18% -286.15%
NOPLAT (mln) -131 -26 -345 -345 -112 -232 -366 -366 -125 -125 -117 -117 -109 -109 -80 -80 -124 -124 -98 -98
Podatek (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Zysk Netto (mln) -131 -26 -345 -345 -112 -232 -366 -366 -125 -125 -117 -117 -109 -109 -80 -80 -124 -124 -98 -98
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% -13.92% 784.8% 6.3% 6.3% 10.8% -46.30% -68.00% -68.00% -12.39% -12.39% -31.47% -31.47% 13.3% 13.3% 21.6% 21.6%
Zysk netto (%) -17591.37% -2179.87% -6833.00% -6833.00% -1714.16% -4112.83% -3863.16% -3863.16% -717.04% -717.04% -529.93% -529.93% -506.75% -506.75% -268.60% -268.60% -552.01% -552.01% -484.63% -484.63%
EPS -1.907 -0.38 -5.02 -5.02 -1.53 -3.15 -3.19 -3.19 -0.29 -0.29 -0.28 -0.28 -0.26 -0.26 -0.19 -0.19 -0.29 -0.29 -0.23 -0.23
EPS (rozwodnione) -1.905 -0.38 -5.02 -5.02 -1.53 -3.15 -3.19 -3.19 -0.29 -0.29 -0.28 -0.28 -0.26 -0.26 -0.19 -0.19 -0.29 -0.29 -0.23 -0.23
Ilośc akcji (mln) 68 68 69 69 74 74 115 115 424 424 424 424 424 424 424 424 425 425 425 425
Ważona ilośc akcji (mln) 69 69 69 69 74 74 115 115 424 424 424 424 424 424 424 424 425 425 425 425
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY HKD CNY CNY CNY CNY CNY